Before revision: These include podoplanin (PDPN), vascular endothelial growth factor receptor 2/kinase insert domain receptor ( VEFR2 /KDR), and transmembrane protein 163 (TMEM163) receptors.
After revision: These include podoplanin (PDPN), vascular endothelial growth factor receptor 2/kinase insert domain receptor ( VEGFR2 /KDR), and transmembrane protein 163 (TMEM163) receptors.